The risks of a possible new diet pill and a thirteen year old weight loss medicine face American investigation as medical experts consider whether or not the drugs’ benefits outweigh their potential side effects.
Arena Pharmaceuticals Inc is going to go before an advisory panel which consider whether or not the pill, lorcaserin or Lorqess, ought to be approved. The medicine is crucial for Arena, a small company which has no other approved drugs in the marketplace.
This consideration will be made at a time when the committee decides whether or not to recommend tougher action against Abbott Laboratories Inc’s diet pill Meridia regarding concerns about heart problems.
The Food and Drug Administration will make the final decision.
Drug manufacturers have not as yet succeeded to produce a diet pill which aids individuals to lose significant weight without serious side effects.